MA20-MA5 Bear Crossover Stocks (Feb 04)

NASDAQ: AMGN (Amgen Inc)

NASDAQ: AMGN (Amgen Inc) has closed at $115.78, its traded Volume was 5013.58K shares, AMGN opened the Day at $117.33, it made an intraday Low of $115.71, and an intraday High of $117.73. AMGN (Amgen Inc) 52-week High is $124.46, 52-week Low is: $81.856, it has supports at $109.7 and $91.27, resistances at $118.81 and $124.45. AMGN’s earning is $6.3 per share, Next quarter estimated EPS is $2.07, current year estimated EPS is $8.17. Its PE ratio is 18. Overall, this stock is rated SELL today.

NYSE: BSX (Boston Scientific Corp)

NYSE: BSX (Boston Scientific Corp) has closed at $12.85, its traded Volume was 29016.9K shares, BSX opened the Day at $13.1, it made an intraday Low of $12.595, and an intraday High of $13.49. BSX (Boston Scientific Corp) 52-week High is $14.08, 52-week Low is: $7.07, it has supports at $12.24 and $11.11, resistances at $14.07 and $16.43. BSX’s earning is $-0.12 per share, Next quarter estimated EPS is $0.12, current year estimated EPS is $0.45. Its PE ratio is -107. Overall, this stock is rated SELL today.

NYSE: CFN (Carefusion Corp)

NYSE: CFN (Carefusion Corp) has closed at $38.64, its traded Volume was 6285.48K shares, CFN opened the Day at $38, it made an intraday Low of $38, and an intraday High of $39.47. CFN (Carefusion Corp) 52-week High is $41.98, 52-week Low is: $30.75, it has supports at $37.59 and $31.27, resistances at $40.29 and $41.97. CFN’s earning is $1.71 per share, Next quarter estimated EPS is $0.66, current year estimated EPS is $2.34. Its PE ratio is 23. . Overall, this stock is rated STRONG SELL today.

NASDAQ: CTIC (Cell Therapeutics)

NASDAQ: CTIC (Cell Therapeutics) has closed at $3.06, its traded Volume was 4295.78K shares, CTIC opened the Day at $3.08, it made an intraday Low of $3.01, and an intraday High of $3.15. CTIC (Cell Therapeutics) 52-week High is $4.25, 52-week Low is: $0.97, it has supports at $2.66 and $1.69, resistances at $4.25 and $4.96. CTIC’s earning is $-0.75 per share, Next quarter estimated EPS is $-0.23, current year estimated EPS is $-0.69. Its PE ratio is -4. Overall, this stock is rated SELL today.

NASDAQ: PDLI (Pdl Biopharma)

NASDAQ: PDLI (Pdl Biopharma) has closed at $8.38, its traded Volume was 4517.36K shares, PDLI opened the Day at $8.9, it made an intraday Low of $8.36, and an intraday High of $8.9. PDLI (Pdl Biopharma) 52-week High is $10.058, 52-week Low is: $6.277, it has supports at $7.92 and $6.58, resistances at $9.23 and $10.05. PDLI’s earning is $1.51 per share, Next quarter estimated EPS is $0.45, current year estimated EPS is $1.77. Its PE ratio is 6. . Overall, this stock is rated STRONG SELL today.